e-therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. e-therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 50% to $477,000. Profit margin reached -1691%. Total operating expenses were $9,826,000.
Profit Margin
| 2010 | 0 | -1.77M | |
|---|---|---|---|
| 2011 | 0 | -2.31M | |
| 2012 | 0 | -3.24M | |
| 2015 | 0 | -7.77M | |
| 2016 | 0 | -8.82M | |
| 2018 | 0 | -5.35M | |
| 2019 | 44K | -3.99M | -9088.64% |
| 2021 | 317K | -3.68M | -1162.15% |
| 2022 | 477K | -8.06M | -1691.19% |
ETX.L Income Statement (2010 – 2021)
| 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 477K | 317K | 44K | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 62K | 73K | 0 | 0 | 0 | 0 |
Gross profit | 477K | 317K | 44K | -62K | -73K | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 6.10M | 2.70M | 3.67M | 5.01M | 9.96M | 8.54M | 2.89M | 1.67M | 1.69M |
Selling and marketing | -217K | -106K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.82M | 4.69M | 5.15M | 6.76M | 11.55M | 10.17M | 4.02M | 2.47M | 2.16M |
Operating income | -9.54M | -4.45M | -5.11M | -6.76M | -11.55M | -10.17M | -4.02M | -2.47M | -2.16M |
Other income (expenses), net | 26K | -13K | 29K | 49K | 271K | 357K | 165K | 180K | 93K |
Income before tax | -9.51M | -4.46M | -5.08M | -6.71M | -11.28M | -9.81M | -3.86M | -2.65M | -2.25M |
Income tax expense | -1.44M | -784K | 1.08M | 1.36M | 2.46M | 2.04M | -621K | -342K | -476K |
Net income | -8.06M | -3.68M | -3.99M | -5.35M | -8.82M | -7.77M | -3.24M | -2.31M | -1.77M |
Earnings per share | |||||||||
Basic EPS | -0.01 | -0.00 | -0.01 | -0.02 | -0.03 | -0.02 | -0.02 | -0.03 | -0.02 |
Diluted EPS | -0.01 | -0.00 | -0.01 | -0.02 | -0.03 | -0.02 | -0.02 | -0.03 | -0.02 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |